Dhruv Dev

Dhruv Dev

Auto-generated profile, based on publicly available information

Dhruv Dev

Department of Pharmacy, Shivalik College of Pharmacy Nangal

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2024 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
APAnasuya Patil
Anasuya Patil
GSGurinderdeep Singh
Gurinderdeep Singh
RDRajendra Dnyandeo Dighe
Rajendra Dnyandeo Dighe
DDDhruv Dev
Dhruv Dev
BPBhaveshkumar A. Patel
Bhaveshkumar A. Patel
GTGAURAV TIWARI
GAURAV TIWARI

26 November 2024 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
RTRUCHI TIWARI
RUCHI TIWARI
DDDhruv Dev
Dhruv Dev
MTMaharshi Thalla
Maharshi Thalla
VAVaibhav Dagaji Aher
Vaibhav Dagaji Aher
AMAnand Badrivishal Mundada
Anand Badrivishal Mundada
KVKrishna Vaghela
Krishna Vaghela
The combination of pharmacogenomics and nanotechnology science of pharmacogenomics into a highly advanced single entity has given birth to personalized medicine known as nano-enabled pharmacogenomics. This review article covers all aspects starting from pharmacogenomics to gene editing tools, how these have evolved or are likely to be evolved for pharmacogenomic application, and how these can be delivered using nanoparticle delivery systems. In this prior work, we explore the evolution of pharmacogenomics over the years, as well as new achievements in the field of genomic sciences, the challenges in drug creation, and application of the strategy of personalized medicine. Particular attention is paid to how nanotechnology helps avoid the problems that accompanied the development of pharmacogenomics earlier, for example, the question of drug resistance and targeted delivery. We also review the latest developments in nano-enabled pharmacogenomics, such as the coupling with other nanobio-technologies, artificial intelligence, and machine learning in pharmacogenomics, and the ethical and regulatory aspects of these developing technologies. The possible uses of nanotechnology in improving the chances of pated and treating drug-resistant cancers are exemplified by case studies together with the current clinical uses of nanotechnology. In the last section, we discuss the future trends and research prospects in this dynamically growing area, stressing the importance of further advancements and collaborations which will advance the nano-enabled pharmacogenomics to their maximum potential.

15 October 2020 in International Journal of Pharmaceutical Chemistry and Analysis
Verified
Journal Article
Open access
PDF file
MSMohammad Shahnaz
Mohammad Shahnaz
SSShivani Sharma
Shivani Sharma
DDDhruv Dev
Dhruv Dev
DPD N Prasad
D N Prasad
Cultivation technology and antibacterial activity of Agaricus bisporus (U-03)-IJPCA-Print ISSN No:-2394-2789 Online ISSN No:-2394-2797Article DOI No:-10.18231/j.ijpca.2020.021,International Journal of Pharmaceutical Chemistry and Analysis-IP Innovative Publication Pvt Limited, Medical Journals Publication, Open Acces

17 April 2026
Verified
Book Chapter
Closed access
RTRUCHI TIWARI
RUCHI TIWARI
PSPrabhu R. Senthil
Prabhu R. Senthil
FMFarhad F. Mehta
Farhad F. Mehta
KTK. Thejomoorthy
K. Thejomoorthy
TGT.K. Gopal
T.K. Gopal
SDSonali K. Diwate
Sonali K. Diwate

17 April 2026
Verified
Book Chapter
Closed access
GTGAURAV TIWARI
GAURAV TIWARI
RGRanjit Vinayak Gadhave
Ranjit Vinayak Gadhave
SMSomashekhar M Metri
Somashekhar M Metri
DDDhruv Dev
Dhruv Dev
SPShubhangi Vijaykumar Pawar
Shubhangi Vijaykumar Pawar
PKPunam Radhesham Kela
Punam Radhesham Kela